Clinical Trial Update: Effect of Losartan on the Neurohumoral Axis and Ventricular Remodeling of Patients With Severe Aortic Regurgitation Undergoing Valve Surgery. [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial investigates whether losartan modulates the neurohumoral axis and reduces ventricular remodeling in patients with severe aortic regu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Regurgitation
• Heart Failure
• Valvular Heart Disease

Drugs mentioned

• Losartan (losartan)

Snippet

Sponsor: Vitor Emer Egypto Rosa | Conditions: Heart Valve Diseases, Left Ventricle Remodeling | Phase 4 | Status: RECRUITING